Get the Stockscreener App
10.78
0.74%
-0.08
After Hours:
10.75
-0.03
-0.28%
Oric Pharmaceuticals Inc stock is traded at $10.78, with a volume of 906.23K.
It is down -0.74% in the last 24 hours and up +13.24% over the past month.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.
See More
Previous Close:
$10.86
Open:
$10.76
24h Volume:
906.23K
Relative Volume:
0.92
Market Cap:
$1.05B
Revenue:
-
Net Income/Loss:
$-137.25M
P/E Ratio:
-5.7037
EPS:
-1.89
Net Cash Flow:
$-121.97M
1W Performance:
-0.92%
1M Performance:
+13.24%
6M Performance:
+34.75%
1Y Performance:
+18.98%
1-Day Range:
$10.76
$11.10
1-Week Range:
$10.36
$11.20
52-Week Range:
$3.8951
$14.67
Oric Pharmaceuticals Inc Stock (ORIC) Company Profile
Name
Oric Pharmaceuticals Inc
Sector
Industry
Phone
(650) 388-5600
Address
240 E. GRAND AVE., SOUTH SAN FRANCISCO, CA
Compare ORIC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ORIC
Oric Pharmaceuticals Inc
|
10.78 | 1.02B | 0 | -137.25M | -121.97M | -1.89 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Oric Pharmaceuticals Inc Stock (ORIC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-04-25 | Resumed | Guggenheim | Buy |
| Jul-08-25 | Initiated | Ladenburg Thalmann | Buy |
| Oct-31-24 | Initiated | Wells Fargo | Overweight |
| Sep-06-24 | Initiated | Stifel | Buy |
| Feb-23-24 | Initiated | Cantor Fitzgerald | Overweight |
| Sep-22-23 | Initiated | Wedbush | Outperform |
| Mar-23-23 | Upgrade | H.C. Wainwright | Neutral → Buy |
| Mar-21-23 | Upgrade | Guggenheim | Neutral → Buy |
| Mar-16-23 | Upgrade | Oppenheimer | Perform → Outperform |
| Jul-18-22 | Resumed | Oppenheimer | Perform |
| Apr-04-22 | Upgrade | Citigroup | Neutral → Buy |
| Mar-25-22 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Mar-22-22 | Downgrade | Citigroup | Buy → Neutral |
| Mar-22-22 | Downgrade | Guggenheim | Buy → Neutral |
| Mar-22-22 | Downgrade | Oppenheimer | Outperform → Perform |
| Jul-06-21 | Upgrade | Citigroup | Neutral → Buy |
| Jan-25-21 | Downgrade | Citigroup | Buy → Neutral |
| Aug-13-20 | Initiated | Robert W. Baird | Outperform |
| Aug-06-20 | Upgrade | Citigroup | Neutral → Buy |
| Aug-03-20 | Initiated | H.C. Wainwright | Buy |
| May-19-20 | Initiated | Citigroup | Neutral |
| May-19-20 | Initiated | Guggenheim | Buy |
| May-19-20 | Initiated | JP Morgan | Overweight |
| May-19-20 | Initiated | Jefferies | Buy |
View All
Oric Pharmaceuticals Inc Stock (ORIC) Latest News
Published on: 2025-09-12 19:32:52 - Newser
Exit strategy if you’re trapped in ORIC Pharmaceuticals Inc.Market Growth Review & Step-by-Step Trade Execution Guides - Newser
Custom strategy builders for tracking ORIC Pharmaceuticals Inc.Price Action & Reliable Price Breakout Signals - Newser
Is ORIC Pharmaceuticals Inc. meeting your algorithmic filter criteriaJuly 2025 Breakouts & Safe Swing Trade Setups - Newser
Published on: 2025-09-12 14:49:38 - Newser
What machine learning models say about ORIC Pharmaceuticals Inc.2025 Momentum Check & Low Drawdown Trading Strategies - Newser
Forecasting ORIC Pharmaceuticals Inc. price range with options dataMarket Risk Report & Consistent Income Trade Recommendations - Newser
Using Bollinger Bands to evaluate ORIC Pharmaceuticals Inc.July 2025 PostEarnings & Verified Trade Idea Suggestions - Newser
Will ORIC Pharmaceuticals Inc. benefit from macro trendsJuly 2025 Rallies & Fast Exit and Entry Strategy Plans - Newser
What’s the recovery path for long term holders of ORIC Pharmaceuticals Inc.Quarterly Trade Summary & Free Verified High Yield Trade Plans - Newser
Is a relief rally coming for ORIC Pharmaceuticals Inc. holdersOil Prices & Short-Term High Return Ideas - Newser
Key metrics from ORIC Pharmaceuticals Inc.’s quarterly dataMarket Risk Analysis & Growth Focused Stock Reports - Newser
Parkman Healthcare Partners LLC Makes New $1.13 Million Investment in Oric Pharmaceuticals, Inc. $ORIC - MarketBeat
Fred Alger Management LLC Sells 40,554 Shares of Oric Pharmaceuticals, Inc. $ORIC - MarketBeat
Is ORIC Pharmaceuticals Inc. stock bottoming outMarket Performance Recap & Real-Time Volume Surge Alerts - Newser
Applying Elliott Wave Theory to ORIC Pharmaceuticals Inc.July 2025 EndofMonth & Risk Controlled Stock Alerts - Newser
Real time pattern detection on ORIC Pharmaceuticals Inc. stock2025 Earnings Impact & High Accuracy Investment Signals - Newser
Volume spikes in ORIC Pharmaceuticals Inc. stock – what they meanQuarterly Market Summary & Precise Trade Entry Recommendations - Newser
Published on: 2025-09-11 04:33:16 - Newser
Published on: 2025-09-11 01:43:44 - Newser
Trexquant Investment LP Invests $425,000 in Oric Pharmaceuticals, Inc. $ORIC - MarketBeat
Signal strength of ORIC Pharmaceuticals Inc. stock in tech scanners2025 Bull vs Bear & Growth-Oriented Investment Plans - Newser
Is ORIC Pharmaceuticals Inc. still worth holding after the dip2025 Price Momentum & Risk Managed Trade Strategies - Newser
Using economic indicators to assess ORIC Pharmaceuticals Inc. potentialPortfolio Performance Summary & Short-Term High Return Ideas - Newser
Will earnings trigger a reversal in ORIC Pharmaceuticals Inc.2025 Market Overview & AI Enhanced Execution Alerts - Newser
Combining machine learning predictions for ORIC Pharmaceuticals Inc.July 2025 Review & Comprehensive Market Scan Reports - Newser
Rafferty Asset Management LLC Purchases 26,032 Shares of Oric Pharmaceuticals, Inc. $ORIC - MarketBeat
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(4) - MarketScreener
Published on: 2025-09-08 13:24:24 - beatles.ru
MPM Bioimpact LLC Invests $7.81 Million in Oric Pharmaceuticals, Inc. $ORIC - MarketBeat
Alkeon Capital Management LLC Boosts Holdings in Oric Pharmaceuticals, Inc. $ORIC - MarketBeat
Oric Pharmaceuticals, Inc. $ORIC Shares Sold by Frazier Life Sciences Management L.P. - MarketBeat
Nuveen LLC Purchases Shares of 167,502 Oric Pharmaceuticals, Inc. $ORIC - MarketBeat
Is ORIC Pharmaceuticals Inc. a cyclical or defensive stockJuly 2025 Fed Impact & Weekly High Conviction Trade Ideas - خودرو بانک
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) | ORIC Stock News - GuruFocus
Oric Pharmaceuticals Inc Stock (ORIC) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):